Erste Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Erste Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.2M	Sell	205,000 -5,000	-2%	-$502K	0.2%	118
2026 Q1	$18.5M	Sell	210,000 -40,000	-16%	-$3.76M	0.17%	133
2025 Q4	$19.8M	Hold	250,000	–	–	0.17%	130
2025 Q3	$18.2M	Sell	250,000 -10,000	-4%	-$636K	0.18%	133
2025 Q2	$13.2M	Hold	260,000	–	–	0.11%	166
2025 Q1	$11.7M	Hold	260,000	–	–	0.15%	144
2024 Q4	$10.7M	Hold	260,000	–	–	0.13%	154
2024 Q3	$10.1M	Hold	260,000	–	–	0.12%	163
2024 Q2	$8.86M	Hold	260,000	–	–	0.12%	163
2024 Q1	$6.53M	Buy	260,000 +25,000	+11%	+$687K	0.09%	201
2023 Q4	$6.95M	Buy	235,000 +10,000	+4%	+$303K	0.1%	184
2023 Q3	$7.11M	Buy	+225,000	New	+$6.16M	0.12%	174

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Erste Asset Management's MIRM Position: Q2 2026 in Review

Erste Asset Management reduced its Mirum Pharmaceuticals (MIRM) stake by 2.4% in Q2 2026, selling an estimated $502K and leaving 205,000 shares worth $25.2M. The position accounts for 0.2% of the portfolio, ranked #118.

Erste Asset Management first reported a position in MIRM in Q3 2023 and has held it in 12 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Erste Asset Management held 205,000 shares of Mirum Pharmaceuticals worth $25.2M as of Q2 2026.
Erste Asset Management sold 5,000 Mirum Pharmaceuticals shares in Q2 2026, an estimated $502K.
Mirum Pharmaceuticals made up 0.2% of Erste Asset Management's portfolio in Q2 2026, its #118 holding.
Erste Asset Management first reported a position in Mirum Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.